Zentek Ltd. is an ISO 13485-certified intellectual property development and commercialization company headquartered in Guelph, Ontario, Canada, that specializes in nanotechnology and advanced materials. Operating as a portfolio of complementary businesses, Zentek develops and commercializes three core brands: ZenGUARD™, a graphene-based antimicrobial coating technology applied to surgical masks and HVAC filters to enhance viral filtration efficiency; Triera Biosciences, a wholly owned biotech brand built on an exclusive aptamer platform for rapid therapeutic development targeting infectious diseases; and Albany Graphite, a high-purity graphite deposit in Northern Ontario positioned to supply electric vehicle battery anodes, nuclear applications, and advanced materials for North American critical-minerals supply chains. The company leverages centralized regulatory, quality, and commercialization expertise supported by an industrial-scale production facility, while pursuing multiple paths to value creation including product revenue, government contracts, strategic partnerships, and licensing arrangements. Zentek's model emphasizes owning and stewarding intellectual property across graphene-based coatings, aptamer platforms, and high-purity graphite technologies, allocating capital and resources based on risk-adjusted return potential.